No Data
The highest single transaction price exceeds 0.5 million yuan! The small peak in medical beauty before the festival "arrives as scheduled", and the differentiation of Institutions intensifies further | Fax.
① With the Spring Festival approaching, the medical beauty Industry is experiencing a small surge in Consumer spending, and medium to large medical beauty Institutions have recently seen a significant increase in customer flow. ② Hyaluronic acid, facial rejuvenation injections, and collagen, which have short recovery times and clear effects, remain the "favorites" of Consumers before the holiday. ③ The differentiation among medical beauty Institutions of different sizes is intensifying.
HAOHAI BIOTEC (06826.HK) spent 1.229 million yuan to buy back 0.0214 million A-shares on January 16.
Gelonghui reported on January 16 that HAOHAI BIOTEC (06826.HK) announced it spent 1.229 million yuan to repurchase 0.0214 million A-shares on January 16, 2025, with a repurchase price per share of 57.34-57.55 yuan.
HAOHAI BIOTEC (06826.HK) spent 0.9383 million yuan to repurchase 0.0164 million A-shares on January 15.
Gelonghui reported on January 15 that HAOHAI BIOTEC (06826.HK) announced that on January 15, 2025, it spent 0.9383 million yuan to repurchase 0.0164 million A-shares, with a repurchase price of 57.07-57.44 yuan per share.
HAOHAI BIOTEC (06826.HK) spent 0.53 million Hong Kong dollars to repurchase 0.022 million shares on January 13.
Gelonghui reported on January 13 that HAOHAI BIOTEC (06826.HK) announced that on January 13, it spent 0.53 million Hong Kong dollars to repurchase 0.022 million shares.
HAOHAI BIOTEC (06826) spent 0.4923 million HKD to buy back 0.02 million shares on January 10.
HAOHAI BIOTEC (06826) announced that on January 10, 2025, the company invested 0.4923 million...
HAOHAI BIOTEC (06826) spent HKD 0.6519 million on January 9 to repurchase 0.026 million shares.
HAOHAI BIOTEC (06826) announced that it will spend 0.6519 million Hong Kong dollars to repurchase shares on January 9, 2025...
Investors Interested In Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) Earnings
